The Egyptian Drug Authority (EDA) released the Regulatory Guideline for Registration of Locally Manufactured Medical Devices Not Holding International Quality Certificates (Code: EDREX: GL. CAMD.09, Version 2) — establishing clear procedures, technical requirements, and compliance pathways for Egyptian manufacturers of medical devices that do not hold internationally recognized quality certificates such as CE marking.

Purpose and Scope

Unlike imported devices or locally produced devices with international quality certifications, many medical devices manufactured in Egypt lack standardized global quality certifications. This guideline sets out the regulatory requirements and registration process for such devices to ensure they meet safety, quality, and effectiveness standards before being marketed or distributed within the country.

Key Definitions and Device Classification

The guideline defines essential terms and classifications used throughout the regulatory process:

• Medical Device: Any instrument, apparatus, software, material or similar product intended for human medical purposes but not acting primarily through pharmacological, immunological, or metabolic means.
• Locally Manufactured Medical Device: A device manufactured within factories located in the Arab Republic of Egypt.
• Registration License: The official EDA approval authorizing the manufacture, marketing, and distribution of the device in Egypt.
• Device Classification: Devices are classified according to risk (Class I, IIa, IIb, III), similar to international systems. Certain manufacturing requirements apply depending on classification.

Pre-Registration Requirements

Before a device can formally enter the registration process, manufacturers must undertake several preparatory steps:

1. Factory Licensing and Technical Compliance:
   Local manufacturers must obtain a technical operation license from EDA’s General Administration of Licensing, demonstrating that the manufacturing site meets Good Manufacturing Practices (GMP) and technical requirements. Within 20 working days of submission, the EDA inspects the facility and notifies corrective actions if needed.
2. Corrective and Compliance Period:
   Manufacturers are given up to 120 working days to implement required corrective actions; this period may be extended by an additional 40 working days if necessary. Upon completion, a compliance inspection is conducted and reported.
3. Pilot Batch Production and Sampling:
   Pilot production batches may be manufactured and used for laboratory testing and analysis, but not placed on the market until registration requirements are completed. The EDA or approved laboratories will analyze samples from these batches as part of registration.

Registration Submission and Analysis

Once the pre-registration requirements are fulfilled:

• Manufacturers submit a registration application through the EDA’s online portal (medevice.edaegypt.gov.eg).
• The EDA’s Medical Devices Inspection Department withdraws samples from the pilot batch for analytical evaluation.
• Applicants must provide a comprehensive analysis file, including required documentation and test results.

The guideline also specifies technical documentation required for different device classes, covering quality control data, performance evidence, risk management, and manufacturing practices appropriate for the device type.

Technical Requirements for Manufacturing Sites

To ensure consistent production quality across locally manufactured devices, the guideline outlines detailed factory requirements, including:

• Adequate facility infrastructure and hygiene standards
• Designated controlled and cleanroom areas
• Proper ventilation, water treatment systems, and laboratory facilities
• Separate storage areas for raw materials and finished products
• Compliance with environmental controls and occupational safety standards

These requirements align internationally recognized principles of quality and help ensure that devices produced locally are safe and effective.

General Requirements and Vigilance

The guideline includes provisions to ensure ongoing monitoring and safety of registered devices, including reporting obligations for manufacturers and vigilance system requirements. It also provides annexes listing detailed supporting documents, factory technical specifications, and safety reporting frameworks.

Practical Implications for Local Industry

This guideline is part of the EDA’s broader effort to support medical device industry growth in Egypt while safeguarding public health. By providing a tailored regulatory pathway for devices without international certification, the EDA enables local innovation and production of medical technologies that meet national standards.

Local manufacturers now have clear steps to follow, from facility compliance and pilot production to document submission and analytical evaluation, which increases regulatory predictability and aligns domestic standards with internationally recognized quality principles.

Conclusion

The Regulatory Guideline for Registration of Locally Manufactured Medical Devices Without International Quality Certificates (Version 2, 2025) provides a comprehensive, structured, and quality-focused framework for Egyptian manufacturers seeking market authorization. By clarifying technical requirements, inspection processes, and submission pathways, the EDA enhances both regulatory transparency and public health protection, contributing to the development of a robust local medical device industry.